Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration
Overview
Authors
Affiliations
Recent work suggested that the activity of extracellular signal-regulated kinase 1/2 (ERK1/2) is increased in the retinal pigment epithelium (RPE) of age-related macular degeneration (ARMD) patients and therefore could be an attractive therapeutic target. Notably, ERK1/2 pathway inhibitors are used in cancer therapy, with severe and noncharacterized ocular side effects. To decipher the role of ERK1/2 in RPE cells, we conditionally disrupted the and genes in mouse RPE. The loss of ERK1/2 activity resulted in a significant decrease in the level of RPE65 expression, a decrease in ocular retinoid levels concomitant with low visual function, and a rapid disorganization of RPE cells, ultimately leading to retinal degeneration. Our results identify the ERK1/2 pathway as a direct regulator of the visual cycle and a critical component of the viability of RPE and photoreceptor cells. Moreover, our results caution about the need for a very fine adjustment of kinase inhibition in cancer or ARMD treatment in order to avoid ocular side effects.
Yang Y, Chien Y, Yarmishyn A, Lim L, Tsai H, Kuo W J Adv Res. 2023; 60:141-157.
PMID: 37328058 PMC: 11156608. DOI: 10.1016/j.jare.2023.06.004.
Mijiti M, Maimaiti A, Chen X, Tuersun M, Dilixiati M, Dilixiati Y Mol Med. 2023; 29(1):64.
PMID: 37183261 PMC: 10183247. DOI: 10.1186/s10020-023-00652-3.
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges.
Moustardas P, Aberdam D, Lagali N Cells. 2023; 12(4).
PMID: 36831285 PMC: 9954064. DOI: 10.3390/cells12040617.
Ramkumar S, Parmar V, Samuels I, Berger N, Jastrzebska B, von Lintig J Hum Mol Genet. 2021; 31(4):548-560.
PMID: 34508587 PMC: 8863423. DOI: 10.1093/hmg/ddab267.
Hsu D, Kwon J, Ng R, Makita S, Yasuno Y, Sarunic M Biomed Opt Express. 2021; 11(12):6945-6961.
PMID: 33408972 PMC: 7747897. DOI: 10.1364/BOE.403209.